For research use only. Not for therapeutic Use.
Triazavirin（Cat No.:I017209）is a broad-spectrum antiviral agent derived from the triazole family, designed to inhibit viral RNA synthesis. It is effective against a wide range of RNA viruses, including influenza, hemorrhagic fever, and respiratory infections. Triazavirin works by interfering with viral replication, thus reducing viral load and the severity of infections. It is particularly valuable in treating viral infections where other treatments may be less effective. With its broad antiviral activity, Triazavirin is a promising therapeutic option for managing emerging viral diseases and pandemics, especially RNA-based viruses.
| Catalog Number | I017209 |
| CAS Number | 928659-17-0 |
| Molecular Formula | C₅H₇N₆NaO₅S |
| Purity | ≥95% |
| Target | Anti-infection |
| IUPAC Name | sodium;7-methylsulfanyl-3-nitro-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-olate;dihydrate |
| InChI | InChI=1S/C5H4N6O3S.Na.2H2O/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5;;;/h12H,1H3;;2*1H2/q;+1;;/p-1 |
| InChIKey | GDVSBVWTWGUDAW-UHFFFAOYSA-M |
| SMILES | CSC1=NN2C(=C(N=NC2=N1)[N+](=O)[O-])[O-].O.O.[Na+] |
| Reference | [1]. Kozhikhova KV, et al. Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin. Pharm Dev Technol. 2018 Apr;23(4):334-342.<br>[2]. Loginova SIa, et al. Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture. Antibiot Khimioter. 2014;59(1-2):3-5.<br>[3]. Loginova SY, et al. Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice. Antibiot Khimioter. 2015;60(7-8):11-3. |
